In the stock market realm, nothing quite matches the rollercoaster ride of Doma Holdings Inc. (DOMA). The company recently made headlines by embarking on a merger journey with TRG, soaring to the heavens at a staggering $6.29 per share in cash, only to witness a rapid descent not long after.

As the curtains lifted on pre-market trading, Doma Holdings shares skyrocketed by a jaw-dropping 34.1%, landing at $6.09, sending shockwaves through the market.

Venture with us now into the tumultuous terrain of pre-market trading, a riveting world where stocks dance to the beat of their internal symphonies while investors watch with bated breath.

Stocks in Celebration

• Vast Renewables Limited (VSTE) embraced the spotlight, leaping a staggering 213.9% to $9.70 after a breathtaking 39% surge the day before, leaving spectators in awe.
• MediaCo Holding Inc. (MDIA) found its rhythm, dancing up 84% to $0.9601 in pre-market trading, following a brief stumble of more than 17% just a day before.
• Galera Therapeutics, Inc. (GRTX) climbed 49.5% to $0.2093 in pre-market trading, unveiling its fourth-quarter performance like a magician revealing the secrets of its trade.
• Qilian International Holding Group Limited (QLI) joined the revelry, gaining 32.2% to $0.8399 in pre-market trading, writing a new chapter in its market narrative.
• Sunshine Biopharma, Inc. (SBFM) rose 30.7% to $0.0791 in pre-market trading, celebrating its fiscal year achievements with a dance of growth and progress.
• Xilio Therapeutics, Inc. (XLO) saw its shares ascend by 26.8% to $1.37 in pre-market trading, as it donned the hat of exclusivity with Gilead Sciences, each step a testament to its newfound partnership.
• Zapata Computing Holdings Inc. (ZPTA) clinched a 10.3% gain, reaching $15.01 in pre-market trading, a victory lap in the unpredictable stock market race.
• Torrid Holdings Inc. (CURV) took a leap, rising 13.9% to $5.5579 in pre-market trading, waltzing through the financial landscape with better-than-expected fourth-quarter results.
• PAVmed Inc. (PAVM) surged 8% to $2.31 in pre-market trading, a phoenix rising from the ashes of a preceding 20% dip, steering its ship towards calmer waters.

Stocks in Commiseration

• Mountain Crest Acquisition Corp. IV (MCAF) faced a harsh reality, plummeting 58.7% to $5.99 in pre-market trading after a transformative business union with CH Auto Technology.
• Fractyl Health, Inc. (GUTS) navigated a rocky path, declining 28.9% to $5.26 in pre-market trading, emerging from FDA approvals and fourth-quarter reports with scars of setbacks.
• ENDRA Life Sciences Inc. (NDRA) stumbled, dropping 28.3% to $0.4157 in pre-market trading after unveiling its fourth-quarter performance, a narrative of highs and lows.
• X3 Holdings Co Ltd. (XTKG) skidded down by 28.1% to $0.7118 in pre-market trading, its strategic partnership unveiling a path laden with unforeseen obstacles.
• Sintx Technologies, Inc. (SINT) slid 22.8% to $0.0382 in pre-market trading after announcing a proposed public offering, a decision echoing louder than the morning bell.
• Vivos Therapeutics, Inc. (VVOS) descended by 18.8% to $3.9220 in pre-market trading, its quarterly results narrating a tale of market tribulations.
• Avalo Therapeutics, Inc. (AVTX) fell 16.4% to $18.19 in pre-market trading, its FY2023 results casting shadows on its financial horizon.
• Applied Therapeutics, Inc. (APLT) witnessed a 14.7% tumble to $5.80 in pre-market trading, its FDA review extension adding a turbulent twist to its market tale.
• CleanSpark, Inc. (CLSK) saw its shares decline by 12.3% to $18.60 in pre-market trading, a dance that followed an analyst’s melody of upwards revision in target price.
• Oxford Industries, Inc. (OXM) stumbled, falling 6% to $105.68 in pre-market trading after reporting a somber fourth quarter, setting the stage for a challenging first quarter ahead.

Now Read This: Top 2 Energy Stocks That Are Preparing To Pump In April